These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28779229)

  • 81. Heart failure and role of circulating MMP-2 and MMP-9.
    Radosinska J; Barancik M; Vrbjar N
    Panminerva Med; 2017 Sep; 59(3):241-253. PubMed ID: 28399617
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy.
    Essa EM; Zile MR; Stroud RE; Rice A; Gumina RJ; Leier CV; Spinale FG
    J Card Fail; 2012 Jun; 18(6):487-92. PubMed ID: 22633307
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Association between matrix metalloproteinase-9 and worsening heart failure events in patients with chronic heart failure.
    Morishita T; Uzui H; Mitsuke Y; Amaya N; Kaseno K; Ishida K; Fukuoka Y; Ikeda H; Tama N; Yamazaki T; Lee JD; Tada H
    ESC Heart Fail; 2017 Aug; 4(3):321-330. PubMed ID: 28772055
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Biological variation of the cardiac index in patients with stable chronic heart failure: inert gas rebreathing compared with impedance cardiography.
    Täger T; Fröhlich H; Franke J; Slottje K; Horsch A; Zdunek D; Hess G; Dösch A; Katus HA; Wians FH; Frankenstein L
    ESC Heart Fail; 2015 Sep; 2(3):112-120. PubMed ID: 27708853
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Association of MMPs and TIMPs With the Occurrence of Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Liu Y; Xu B; Wu N; Xiang Y; Wu L; Zhang M; Wang J; Chen X; Li Y; Zhong L
    Can J Cardiol; 2016 Jun; 32(6):803-13. PubMed ID: 26907578
    [TBL] [Abstract][Full Text] [Related]  

  • 86. MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.
    Kobusiak-Prokopowicz M; Krzysztofik J; Kaaz K; Jolda-Mydlowska B; Mysiak A
    Open Med (Wars); 2018; 13():237-246. PubMed ID: 29915813
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Association of matrix metalloproteinases with MRI indices of brain ischemia and aging.
    Romero JR; Vasan RS; Beiser AS; Au R; Benjamin EJ; DeCarli C; Wolf PA; Seshadri S
    Neurobiol Aging; 2010 Dec; 31(12):2128-35. PubMed ID: 19128858
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical significance of matrix metalloproteinase (MMP)-2 in patients with acute heart failure.
    Shirakabe A; Asai K; Hata N; Yokoyama S; Shinada T; Kobayashi N; Mizuno K
    Int Heart J; 2010; 51(6):404-10. PubMed ID: 21173516
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis.
    Lewiński A; Brona A; Lewandowski K; Skowrońska-Jóźwiak E; Milewicz A
    Thyroid Res; 2012 Oct; 5(1):12. PubMed ID: 23107223
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Role and dynamics of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in burn patients.
    Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Gherghe M; Hainarosie R; Furtunescu FL; Gheorghe DC
    Exp Ther Med; 2021 Oct; 22(4):1062. PubMed ID: 34434276
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Examining variation and temporal dynamics of extracellular matrix biomarkers following acute myocardial infarction.
    Brunton-O'Sullivan MM; Holley AS; Bird GK; Kristono GA; Harding SA; Larsen PD
    Biomark Med; 2022 Feb; 16(3):147-161. PubMed ID: 35107387
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Microcurrent stimulation promotes reverse remodelling in cardiomyocytes.
    Kapeller B; Mueller J; Losert U; Podesser BK; Macfelda K
    ESC Heart Fail; 2016 Jun; 3(2):122-130. PubMed ID: 27774272
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy.
    Frankenstein L; Remppis A; Giannitis E; Frankenstein J; Hess G; Zdunek D; Doesch A; Zugck C; Katus HA
    Clin Res Cardiol; 2011 Aug; 100(8):633-40. PubMed ID: 21327843
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Evaluation of tissue metaloproteinases inhibitors TIMP-2 and TIMP-4 in III-rd trimester of pregnancy].
    Karowicz-Bilińska A; Kowalska-Koprek U; Estemberg D; Sikora-Szubert A
    Ginekol Pol; 2015 Oct; 86(10):737-41. PubMed ID: 26677582
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure.
    Wang L; Wang J; Wang Y; Fu Q; Lei YH; Nie ZY; Qiu J; Bao TY
    Exp Ther Med; 2014 Feb; 7(2):329-334. PubMed ID: 24396399
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community.
    Dhingra R; Pencina MJ; Schrader P; Wang TJ; Levy D; Pencina K; Siwik DA; Colucci WS; Benjamin EJ; Vasan RS
    Circulation; 2009 Mar; 119(8):1101-7. PubMed ID: 19221217
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers.
    Kolano P; Bednarski IA; Kraska-Gacka M; Narbutt J; Lesiak A
    Postepy Dermatol Alergol; 2021 Apr; 38(2):230-234. PubMed ID: 34408591
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Circulating matrix metalloproteinases in infective endocarditis: a possible marker of the embolic risk.
    Thuny F; Habib G; Le Dolley Y; Canault M; Casalta JP; Verdier M; Avierinos JF; Raoult D; Mege JL; Morange PE; Alessi MC
    PLoS One; 2011 Apr; 6(4):e18830. PubMed ID: 21533198
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer.
    Peeney D; Liu Y; Lazaroff C; Gurung S; Stetler-Stevenson WG
    Carcinogenesis; 2022 Jun; 43(5):405-418. PubMed ID: 35436325
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure.
    Gonçalves PR; Nascimento LD; Gerlach RF; Rodrigues KE; Prado AF
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.